Examples of using Adequate data in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Applications for which adequate data are not available.
Adequate data for proper risk assessment of static magnetic fields are very sparse.
Pregnancy There are no adequate data on use of Lopid in pregnant women.
Adequate data do not exist for the use of TOBI Podhaler in patients after organ transplantation.
Risk related to lacosamide There are no adequate data from the use of lacosamide in pregnant women.
People also translate
Adequate data do not exist for the use of inhaled tobramycin in patients after organ transplantation.
For the purpose of informing policymaking, Eurostat should gather adequate data on live-in care workers.
There are no adequate data from the use of tigecycline in pregnant women.
Ensures that contributors to benchmarks provide adequate data and are subject to adequate controls.
There are no adequate data from the use of lasofoxifene in pregnant women.
due to the lack of adequate data on the safety of its use in these patients.
There are no adequate data from the use of tasonermin in pregnant women.
To prevent any unnecessary testing, ECHA looks at all the testing proposals to check that the proposed test is likely to produce reliable and adequate data.
There are no adequate data on the use of oxybutynin topical gel in pregnant women.
The current revision of the Community chemicals policy as outlined in the recent White Paper3 will ensure that sufficient and adequate data for all chemical substances are available.
There are no adequate data on the use of tobramycin via inhalation in pregnant women.
Pregnancy There is no adequate data from the use of glucosamine in pregnant women.
Adequate data are not available to recommend dosage alterations in patients with mild to moderate hepatic impairments see 5.2.
Use in pregnancy There are no adequate data from the use of this medicinal product in pregnant woman.
Adequate data are not available to recommend dose alterations in patients with mild to moderate hepatic impairments see section 4.2.
The study does not need to be conducted if adequate data from a reliable in vivo mammalian gene mutation test are available.
No adequate data for Tier B were provided by the applicant to assess the long-term effects on dung fauna organisms caused by the use of the product.
Pregnancy There are no adequate data with the use of methylnaltrexone bromide in pregnant women.
Adequate data are not available to recommend dosage alterations in patients with mild to moderate hepatic impairment see 4.4 and 5.2.
Nicotinic acid There are no adequate data from the use of high dose nicotinic acid in pregnant women.
There are no adequate data from the use of Telmisartan Teva Pharma in pregnant women.
There are no adequate data from the use of either busulfan
There are no adequate data from the use of pioglitazone
There are no adequate data to support the use of Eperzan during breast-feeding in humans.
There are no adequate data from the use of prolonged-release exenatide in pregnant women.